Hillsdale Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Hillsdale Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-42,110	Closed	-$2.86M	–	697
2019 Q3	$2.86M	Sell	42,110 -1,600	-4%	-$110K	0.25%	123
2019 Q2	$2.54M	Buy	43,710 +2,400	+6%	+$142K	0.25%	92
2019 Q1	$2.89M	Buy	41,310 +1,420	+4%	+$105K	0.26%	61
2018 Q4	$2.57M	Buy	39,890 +12,750	+47%	+$894K	0.3%	49
2018 Q3	$1.91M	Buy	+27,140	New	+$1.59M	0.25%	66

Hillsdale Investment Management's GHDX Position: Q4 2019 in Review

Hillsdale Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 42,110 shares — an estimated $2.86M sold.

Hillsdale Investment Management first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $2.89M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Hillsdale Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Hillsdale Investment Management sold 42,110 Genomic Health, Inc. shares in Q4 2019, an estimated $2.86M.
Hillsdale Investment Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Hillsdale Investment Management's Genomic Health, Inc. position peaked at $2.89M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Hillsdale Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.